BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 4, 2012
View Archived Issues
New B-raf inhibitors presented by Array BioPharma and Genentech
Read More
Ablynx and Merck & Co. enter collaboration for Nanobody candidates
Read More
Intravenous dosing of GSK-322 investigated in healthy subjects
Read More
FDA approves extended-release liquid methylphenidate for ADHD
Read More
Phase III Abraxane trial meets primary endpoint
Read More
Astex begins phase II trial of SGI-110 in platinum-resistant recurrent ovarian cancer
Read More
PolyMedix presents new antimicrobials against biowarfare pathogens
Read More
Ipragliflozin has beneficial effects in Japanese patients with type 2 diabetes
Read More
Eravacycline compared to ertapenem in patients with intra-abdominal infections
Read More
Spanish researchers disclose new immunogenic compositions
Read More
Sanofi patents new 11-beta-HSD1 inhibitors
Read More
Merck Serono creates spin-off company to focus on neurodegenerative diseases
Read More
Ipsen provides update on hemophilia product agreement with Inspiration Biopharmaceuticals
Read More
Thrombolytic Science International begins phase I study of TS-01
Read More
Mallinckrodt completes acquisition
Read More
Athersys updates on MultiStem adult stem cell phase II study
Read More
Curis begins phase I trial of oral formulation of CUDC-101 in solid tumors
Read More
First data on once-weekly DPP IV inhibitor MK-3102 reported
Read More
Development and commercialization agreement reached for velusetrag for gastroparesis
Read More
Servier and EOS conclude collaboration and license agreement for E-3810
Read More
CBL-0102 receives U.S. orphan drug designation for hepatocellular carcinoma
Read More
Sanofi and Bristol-Myers Squibb restructure alliance
Read More
Omeros completes enrollment in second phase III OMS-302 trial
Read More
Phase Ib trial of RG-3039 commences
Read More